Pfizer sues Metsera, Novo Nordisk
Digest more
Novo narrowed its full-year guidance for the fourth time this year, saying it now expects sales growth within the range of 8% ...
COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk lowered its full-year profit and sales forecasts again on Wednesday, in an ...
Novo Nordisk lowers its 2025 profit forecast as new CEO Mike Doustdar faces rising competition, leadership changes, and a ...
Pfizer and Novo Nordisk are in a heated legal and bidding war over Metsera, an obesity drug developer. Novo's $10 billion bid ...
The lawsuit escalates an unusual, high-profile battle between two large pharmaceutical companies over ownership of a coveted ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback